Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy
- 1 September 2003
- journal article
- clinical trial
- Published by Elsevier BV in Kidney International
- Vol. 64 (3), 1027-1034
- https://doi.org/10.1046/j.1523-1755.2003.00175.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- CYCLOSPORINE AND LONG-TERM KIDNEY GRAFT SURVIVALTransplantation, 2001
- Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathyKidney International, 2001
- Impact of Absorption Profiling on Efficacy and Safety of Cyclosporin Therapy in Transplant RecipientsClinical Pharmacokinetics, 2000
- Chronic allograft nephropathy: An updateKidney International, 1999
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- LONG-TERM OUTCOME OF A PROSPECTIVE RANDOMIZED TRIAL OF CONVERSION FROM CYCLOSPORINE TO AZATHIOPRINE TREATMENT ONE YEAR AFTER RENAL TRANSPLANTATION1Transplantation, 1998
- Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapyKidney International, 1996
- PREDICTING GLOMERULAR FILTRATION RATE AFTER KIDNEY TRANSPLANTATIONTransplantation, 1995
- Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantationThe Lancet, 1995
- DAILY RENAL HYPOPERFUSION INDUCED BY CYCLOSPORINE IN PATIENTS WITH RENAL TRANSPLANTATIONTransplantation, 1992